文献速递糖尿病

囊性纤维化相关糖尿病的遗传修饰因子与2型糖尿病及相关特征存在广泛重叠

Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

在5740例囊性纤维化(CF)患者中开展全基因组关联研究,识别CF相关糖尿病(CFRD)的遗传修饰因子,并检验其与1型糖尿病、2型糖尿病及糖尿病中间表型的多基因风险评分(PRS)的关联。研究发现新位点PTMA及已知位点TCF7L2、SLC26A9与CFRD全基因组显著相关;CFRD与T2D、胰岛素分泌、负荷后血糖和空腹血糖的PRS强相关,与胰岛素敏感性PRS关联不一致,与胰岛自身免疫PRS无关。基于筛选变异构建的18变异PRS在独立人群中可分层CFRD风险。

要点

  • CFRD与T2D在β细胞功能通路上遗传重叠显著,而非胰岛素敏感性。
  • PTMA和SLC26A9为CF特异性位点,TCF7L2同时与T2D相关。
  • 18变异PRS可在独立人群中分层CFRD风险。

核心结论

  • CFRD与T2D的病因学和机制重叠比既往所知更广泛,主要沿β细胞功能通路而非胰岛素敏感性通路对齐。
  • 两个CFRD风险位点与T2D无关,可能影响CF的多个方面。
  • 18变异PRS可在独立人群中分层CFRD风险。

研究设计与样本

  • 在5740例囊性纤维化患者中开展CFRD发病的全基因组关联研究。
  • 检验1型糖尿病、2型糖尿病及糖尿病中间表型的加权多基因风险评分(PRS)与CFRD的关联。
  • 在复制人群中验证由PRS筛选变异(错误发现率<0.1)及全基因组显著变异构建的CFRD PRS。

主要发现

  • 在新位点PTMA及2个已知CFRD遗传修饰因子TCF7L2和SLC26A9获得全基因组显著性。
  • PTMA和SLC26A9变异为CF特异性;TCF7L2变异也与T2D相关。
  • CFRD与T2D、胰岛素分泌、负荷后血糖浓度和空腹血浆葡萄糖的PRS强相关,与T1D PRS关联较弱。
  • CFRD与胰岛素敏感性PRS关联不一致,与胰岛自身免疫PRS无关联。
  • 由PRS筛选变异(错误发现率<0.1)及全基因组显著变异构建的CFRD PRS与复制人群中的CFRD相关。

关键数值与推荐

  • 全基因组显著性见于PTMA、TCF7L2和SLC26A9位点变异。
  • PRS筛选采用错误发现率<0.1。
  • 最终构建的PRS包含18个变异。

临床怎么用

  • CFRD遗传风险评估可参考T2D及β细胞功能相关PRS,而非胰岛素敏感性或胰岛自身免疫PRS。
  • 18变异PRS有望用于CFRD风险分层,但需进一步临床验证。
  • PTMA和SLC26A9等CF特异性位点可能为CFRD提供独立于T2D的机制线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Individuals with cystic fibrosis (CF) develop a distinct form of diabetes characterized by β-cell dysfunction and islet amyloid accumulation similar to type 2 diabetes (T2D), but generally have normal insulin sensitivity. CF-related diabetes (CFRD) risk is determined by both CFTR, the gene responsible for CF, and other genetic variants. OBJECTIVE: To identify genetic modifiers of CFRD and determine the genetic overlap with other types of diabetes. DESIGN AND PATIENTS: A genome-wide association study was conducted for CFRD onset on 5740 individuals with CF. Weighted polygenic risk scores (PRSs) for type 1 diabetes (T1D), T2D, and diabetes endophenotypes were tested for association with CFRD. RESULTS: Genome-wide significance was obtained for variants at a novel locus (PTMA) and 2 known CFRD genetic modifiers (TCF7L2 and SLC26A9). PTMA and SLC26A9 variants were CF-specific; TCF7L2 variants also associated with T2D. CFRD was strongly associated with PRSs for T2D, insulin secretion, postchallenge glucose concentration, and fasting plasma glucose, and less strongly with T1D PRSs. CFRD was inconsistently associated with PRSs for insulin sensitivity and was not associated with a PRS for islet autoimmunity. A CFRD PRS comprising variants selected from these PRSs (with a false discovery rate < 0.1) and the genome-wide significant variants was associated with CFRD in a replication population. CONCLUSIONS: CFRD and T2D have more etiologic and mechanistic overlap than previously known, aligning along pathways involving β-cell function rather than insulin sensitivity. Two CFRD risk loci are unrelated to T2D and may affect multiple aspects of CF. An 18-variant PRS stratifies risk of CFRD in an independent population.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Aksit MA, Pace RG, Vecchio-Pagán B, et al. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits. J Clin Endocrinol Metab. 2020. PMID: 31697830. doi:10.1210/clinem/dgz102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。